Stromal issues in cervical cancer: A review of the role and function of basement membrane, stroma, immune response and angiogenesis in cervical cancer development

European Journal of Cancer Prevention

Volumn 19, Issue 3, 2010, Pages 204-215

  Sahebali, Shaira ^a,b   Van Den Eynden, Gert ^a   Murta, Eddie F ^d   Michelin, Marcia A ^e   Cusumano, Pino ^c   Petignat, Patrick ^f   Bogers, Johannes J ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Laboratory for Clinical Pathology   (Belgium)

^c Surgical Gynecologic Oncology Unit   (Belgium)

^d Research Institute of Oncology (IPON) Gynecology and Obstetrics   (Belgium)

^e FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Angiogenesis; Cervical carcinoma; Human papillomavirus; Immune response; Stroma

Indexed keywords

ANGIOGENESIS; BASEMENT MEMBRANE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; DISEASE SEVERITY; EPITHELIUM DYSPLASIA; HUMAN; IMMUNE RESPONSE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; STROMA; UTERINE CERVIX CARCINOMA; WART VIRUS;

BASEMENT MEMBRANE; FEMALE; HUMANS; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PATHOLOGIC; STROMAL CELLS; UTERINE CERVICAL NEOPLASMS;

EID: 77950249129     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32833720de     Document Type: Review

References (164)

1. Abulafia O, Triest W, Sherer D (1996). Angiogenesis in squamous cell carcinoma in situ and microinvasive carcinoma of the uterine cervix. Obstet Gynecol 88:927-932.
2. Adams M, Borysiewicz L, Fiander A, Man S, Jasani B, Navabi H, et al. (2001). Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer. Vaccine 19:2549-2556.
3. Agrawal T, Vats V, Wallace PK, Salhan S, Mittal A (2008). Role of cervical dendritic cell subsets, co-stimulatory molecules, cytokine secretion profile and beta-estradiol in development of sequalae to Chlamydia trachomatis infection. Reprod Biol Endocrinol 6:46.
4. Ala-Aho R, Kahari VM (2005). Collagenases in cancer. Biochimie 87:273-286.
5. Albini A, Sporn MB (2007). The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7:139-147.
6. Alcocer-Gonzalez JM, Berumen J, Tamez-Guerra R, Bermú dez-Morales V, Peralta-Zaragoza O, Hernández-Pando R, (2006). In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells. Viral Immunol 19:481-491.
7. Ansel JC, Luger TA, Lowry D, Perry P, Roop DR, Mountz JD (1988). The expression and modulation of IL-1 alpha in murine keratinocytes. J Immunol 140:2274-2278.
8. Avall-Lundqvist EH, Silfversward C, Aspenblad U, Nilsson B, Auer G (1997). The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma. Eur J Cancer 33:1799-1804.
9. Bagnato A, Cirilli A, Salani D, Simeone P, Muller A, Nicotra MR, et al. (2002). Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade. Cancer Res 62:6381-6384.
10. Bates RC, Bellovin DI, Brown C, Maynard E,Wu B, Kawakatsu H, et al. (2005). Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 115:339-347.
11. Benitez-Bribiesca L, Wong A, Utrera D, Castellanos E (2001). The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem 49:1061-1062.
12. Bequet-Romero M, Lopez-Ocejo O (2000). Angiogenesis modulators expression in culture cell lines positive for HPV-16 oncoproteins. Biochem Biophys Res Commun 277:55-61.
13. Birner P, Schindl M, Obermair A, Breitenecker G, Kowalski H, Oberhuber G (2001). Lymphatic microvessel density as a novel prognostic factor in earlystage invasive cervical cancer. Int J Cancer 95:29-33.
14. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Path 55: 244-265.
15. Boulet GA, Schrauwen I, Sahebali S, Horvath C, Depuydt CE, Vereecken A, et al. (2007). Correlation between laminin-5 immunohistochemistry and human papillomavirus status in squamous cervical carcinoma. J Clin Pathol 60: 896-901.
16. Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Benedetto A, et al. (2006). Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J Clin Pathol 59: 40-47.
17. Brat DJ, Kaur B, Van Meir EG (2003). Genetic modulation of hypoxia induced gene expression and angiogenesis: relevance to brain tumors. Front Biosci 8:d100-d116.
18. Bremer G, Tiebosch A, Van Der Putten HW, Schouten H, De Haan J, Arends J (1996). Tumor angiogenesis: an independent prognostic parameter in cervical cancer. Am J Obstet Gynecol 174:126-131.
19. Brew K, Dinakarpandian D, Nagase H (2000). Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477: 267-283.
20. Burgeson RE, Chiquet M, Deutzmann R, Ekblom P, Engel J, Kleinman H, et al. (1994). A new nomenclature for the laminins. Matrix Biol 14:209-211.
21. Cabanillas-Saez A, Schalper J, Nicovani S, Rudolph M (2002). Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix. Int J Gynecol Cancer 12: 92-98.
22. Cantu De Leon D, Lopez-Graniel C, Frias Mendivil M, Chanona Vilchis G, Gomez C, De La Garza Salazar J (2003). Significance of microvascular density (MVD) in cervical cancer recurrence. Int J Gynecol Cancer 13:856-862.
23. Chen W, Li F, Mead L, White H, Walker J, Ingram D, et al. (2007). Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior. Virology 367:168-174.
24. Clerici M, Merola M, Ferrario E, Trabattoni D, Villa ML, Stefanon B (1996). Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 89:245-250.
25. Cooper R,Wilks D, Logue J, Davidson S, Hunter R, Roberts S, et al. (1998). High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy. Clin Cancer Res 4:2795-2800.
26. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, et al. (1999). Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13:1382-1397.
27. Coussens LM, Tinkle CL, Hanahan D,Werb Z (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481-490.
28. Culp TD, Budgeon LR, Christensen ND (2006a). Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor. Virology 347:147-159.
29. Culp TD, Budgeon LR, Marinkovich MP, Meneguzzi G, Christensen ND (2006b). Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol 80:8940-8950.
30. Dalgleish AG, O'Byrne KJ (2002). Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer. Adv Cancer Res 84:231-276.
31. Davidson B, Goldberg I, Gotlieb WH, Lerner-Geva L, Ben-Baruch G, Agulansky L, et al. (1999a). Macrophage infiltration and angiogenesis in cervical squamous cell carcinoma-clinicopathologic correlation. Acta Obstet Gynecol Scand 78:240-244.
32. Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, et al. (1999b). MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma-a clinico pathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol 73:372-382.
33. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F (1990). Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38:352-357.
34. Dellas A, Moch H, Schultheiss E, Feichter G, Almendral A, Gudat F, et al. (1997). Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations. Gynecol Oncol 67:27-33.
35. Di Leo S, Caschetto S, Garozzo G, Nuciforo G, Cassaro N, Meli M, et al. (1998). Angiogenesis as a prognostic factor in cervical carcinoma. Eur J Gynaecol Oncol 19:158-162.
36. Dinh T, Hannigan E, Smith ER, Hove M, Chopra V, To T (1996). Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix. Obstet Gynecol 87:751-754.
37. Dobbs SP, Hewett P, Johnson I, Carmichael J, Murray J (1997). Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br J Cancer 76:1410-1415.
38. Egeblad M, Werb Z (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174.
39. Engvall E,Wewer UM (1996). Domains of laminin. J Cell Biochem 61:493-501.
40. Evans SM, Schrlau AE, Chalian AA, Zhang P, Koch CJ (2006). Oxygen levels in normal and previously irradiated human skin as assessed by EF5 binding. J Invest Dermatol 126:2596-2606.
41. Fang KC, Wolters PJ, Steinhoff M, Bidgol A, Blount JL, Caughey GH (1999). Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. J Immunol 162:5528-5535.
42. Feldkamp MC, Vreugdenhill GR, Vierboom MP, Ras E, van der Burg SH (1995). Cytotoxic T-lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16 induced tumors. Eur J Immunol 25:2638-2642.
43. Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C (2004). Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48:411-424.
44. Fujimoto J, Sakaguchi H, Hirose R, Ichigo S, Tamaya T (1999). Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers. Br J Cancer 80:827-833.
45. Fujimoto J, Alam S, Jahan I, Sato E, Toyoki H, Hong B, et al. (2006). Plausible linkage of hypoxia inducible factor-1alpha in uterine cervical cancer. Cancer Sci 97:861-867.
46. Fujiwaki R, Hata K, Iida K, Maede Y, Miyazaki K (2000). Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis. Anticancer Res 20:1317-1322.
47. Gius D, Funk MC, Chuang EY, Feng S, Huettner PC, Nguyen L, et al. (2007). Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. Cancer Res 67:7113-7123.
48. Gombos Z, Xu X, Chu C, Zhang PJ, Acs G (2005). Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res 11: 8364-8371.
49. Gonzales-de Leon C, Lippman SM, Kudelka AP, Edwards CL, Kavanagh JJ (1995). Phase II study of cisplatin, 5-fluorouracil and interferon in recurrent carcinoma of the cervix. Invest New Drugs 13:73-76.
50. Gruber BL, Marchese MJ, Suzuki K, Schwartz LB, Okada Y, Nagase H, et al. (1989). Synovial procollagenase activation by human mast-cell tryptase dependence upon matrix metalloproteinase-3 activation. J Clin Invest 84:1657-1662.
51. Guidi AJ, Abu-Jawdeh G, Berse B, Jackman R, Tognazzi K, Dvorak H, et al. (1995). Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 87:1237-1245.
52. Häkkinen L, Hildebrand HC, Berndt A, Kosmehl H, Larjava H (2000). Immunolocalization of tenascin-C, alpha9 integrin subunit, and alphavbeta6 integrin during wound healing in human oral mucosa. J Histochem Cytochem 48:985-998.
53. Hallum AV, Alberts DS, Lippman SM, Inclan I, Shamdas GJ, Childers JM, et al. (1995). Phase II study of 13-cisretinoic acid plus interferon 2a in heavily pretreated squamous carcinoma of the cervix. Gynecol Oncol 56: 382-386.
54. Hashimoto I, Kodama J, Seki N, Hongo A, Yoshinouchi M, Okuda H, et al. (2001). Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer 85:93-97.
55. Hazelbag S, Kenter GG, Gorter A, Dreef EJ, Koopman LA, Violette SM, et al. (2007). Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival. J Pathol 212:316-324.
56. Hernandez P, Merino N, Lopez-Ocejo O, Arana MJ (2000). A mouse fibroblast cell model to study human papillomavirus-associated tumorigenesis. Biochem Biophys Res Commun 270:119-124.
57. Hirakawa T, Kamura T, Kaku T, Amada S, Ariyoshi K, Kinukawa N, et al. (1999). Prognostic significance of epithelial-stromal vascular cuffing and microvessel density in squamous cell carcinoma of the uterine cervix. Gynecol Oncol 74:369-374.
58. Hockel M, Schlenger K, Knoop C, Vaupel P (1991). Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements. Cancer Res 51:6098-6102.
59. Hove MGM, Dinh TV, Hannigan EV, Lucci JA III, Chopra V, Smith ER, et al. (1999). Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix. J Reprod Med 44:493-496.
60. Huang SY, Van Arsdall M, Tedjarati S, McCarty M, Wu WJ, Langley R, et al. (2002). Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94: 1134-1142.
61. II M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y (2006). Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med 231:20-27.
62. Ivansson EL, Gustavsson IM, Magnusson JJ, Steiner LL, Magnusson PK, Erlich HA, Gyllensten UB (2007). Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer. Int J Cancer 121:2451-2457.
63. Jacobs N, Renard I, Al-Saleh W, Hubert P, Doyen J, Kedzia W, et al. (2003). Distinct T cel subsets and cytokine production incultures derived from transformation zone and squamous intraepithelial lesion biopsies of the uterine cervix. Am J Reprod Immunol 49:6-13.
64. Johansson N, Vaalamo M, Grenman S, Hietanen S, Klemi P, Saarialho-Kere U, et al. (1999). Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol 154:469-480.
65. Kadish AS, Ho GY, Burk RD, Wang Y, Romney SL, Ledwidge R (1997). Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. J Natl Cancer Inst 89:1285-1293.
66. Kainz C, Speiser P, Wanner C, Obermair A, Tempfer C, Sliutz G, et al. (1995). Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB to IIB. Anticancer Res 15:1549-1551.
67. Kaku T, Hirakawa T, Kamura T, Amada S, Kinukawa N, Kobayashi H, et al. (1998). Angiogenesis in adenocarcinoma of the uterine cervix. Cancer 83:1384-1390.
68. Kankkunen JP, Harvima IT, Naukkarinen A (1997). Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 72:385-388.
69. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820-827.
70. Kaplan RN, Rafii S, Lyden D (2006). Preparing the soil: the premetastatic niche. Cancer Res 66:11089-11093.
71. Kersemaekers AM, Fleuren GJ, Kenter GC, Van den Broek LJ, Uljee SM, Hermans J, et al. (1999). Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res 5:577-586.
72. Kodama J, Seki N, Tokumo K, Nakanishi Y, Yoshinouchi M, Kudo T (1997). Placenta growth factor is abundantly expressed in human cervical squamous cell carcinoma. Eur J Gynaecol Oncol 18:508-510.
73. Kodama J, Seki N, Tokumo K, Hongo A, Miyagi Y, Yoshinouchi M, et al. (1999a). Vascular endothelial growth factor is implicated in early invasion in cervical cancer. Eur J Cancer 35:485-489.
74. Kodama J, Yoshinouchi M, Seki N, Hongo A, Miyagi Y, Kudo T (1999b). Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in cervical cancer. Int J Oncol 15:149-154.
75. Kodama J, Hashimoto I, Seki N, Hongo A, Yoshinouchi M, Okuda H, et al. (2001). Thrombospondin-1 and-2 messenger RNA expression in invasive cervical cancer: correlation with angiogenesis and prognosis. Clin Cancer Res 7:2826-2831.
76. Kohlberger P, Beneder CH, Horvat R, Leodolter S, Breitenecker G (2003). Immunohistochemical expression of laminin-5 in cervical intraepithelial neoplasia. Gynecol Oncol 89:391-394.
77. Koromilas AE, Li S, Matlashewski G (2001). Control of interferon signaling in human papillomavirus infection. Cytokine Growth Factor Rev 12:157-170.
78. Kyo S, Inoue M, Hayasaka N, Inoue T, Yutsudo M, Tanizawa O, et al. (1994). Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. Virology 200:130-139.
79. Lee J, Kim H, Jung J, Lee M, Park C (2002a). Angiogenesis, cell proliferation and apoptosis in progression of cervical neoplasia. Anal Quant Cytol Histol 24:103-113.
80. Lee J, Kim H, Jung J, Lee M, Park C (2002b). Expression of vascular endothelial growth factor in adenocarcinomas of the uterine cervix and its relation to angiogenesis and p53 and c-erbB-2 protein expression. Gynecol Oncol 85:469-475.
81. Lee J, Kim H, Park J, Lee M, Park C (2003). Expression of vascular endothelial growth factor in the progression of cervical neoplasia and its relation to angiogenesis and p53 status. Anal Quant Cytol Histol 25:303-311.
82. Lee WY, Huang SC, Hsu KF, Tzeng CC, Shen WL (2008). Roles for hypoxiaregulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence. Gynecol Oncol 108:377-384.
83. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL (1996). Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625-4629.
84. Lenczewski A, Terlikowski S, Famulski W, Sulkowska M, Kulikowski M (2001). Angiogenesis as a prognostic factor in invasive carcinoma of the uterine cervix. Folia Histochem Cytobiol 39:165-166.
85. Lohi J (2001). Laminin-5 in the progression of carcinomas. Int J Cancer 94: 763-767.
86. Longatto-Filho A, Pinheiro C, Pereira SM, Etlinger D, Moreira M, Jube L, et al. (2007). Lymphatic vessel density and epithelial D2-40 immunoreactivity in preinvasive and invasive lesions of the uterine cervix. Gynecol Oncol 107:45-51.
87. Longatto-Filho A, Pinheiro C, Martinho O, Moreira MA, Ribeiro LF, Queiroz GS, et al. (2009). Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma. BMC Cancer 9:212.
88. Lopez-Ocejo O, Viloria-Petit A, Bequet-Romero M, Mukhopadhyay D, Rak J, Kerbel R (2000). Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. Oncogene 19:4611-4620.
89. Maddox P, Sasieni P, Szarewski A, Anderson M, Hanby A (1999). Differential expression of keratins 10, 17 and 19 in normal cervical epithelium, cervical intraepithelial neoplasia and cervical carcinoma. J Clin Pathol 52:41-46.
90. Maluf PJ, Michelin MA, Etchebehere RM, Adad SJ, Murta EF (2008). T lymphocytes (CD3) may participate in the recurrence of cervical intraepithelial neoplasia grade III. Arch Gynecol Obstet 278:525-530.
91. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992). The origin and function of tumor-associated macrophages. Immunol Today 13:265-270.
92. Masaki T, Sugiyama M, Matsuoka H, Abe N, Izumisato Y, Sakamoto A, et al. (2003). Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas. Dig Dis Sci 48:1262-1267.
93. Masson V, de la Ballina LR, Munaut C, Wielockx B, Jost M, Maillard C, et al. (2005). Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J 18:234.
94. Mayer A,Wree A, Höckel M, Leo C, Pilch H, Vaupel P (2004). Lack of correlation between expression of HIF-1alpha protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix. Cancer Res 64:5876-5881.
95. Mazibrada J, Rittà M, Mondini M, De Andrea M, Azzimonti B, Borgogna C, et al. (2008). Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol Oncol 108:112-120.
96. Mitchell DG, Snyder B, Coakley F, Reinhold C, Thomas G, Amendola MA, et al. (2009). Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study. Gynecol Oncol 112:95-103.
97. Murphy G, Knauper V, Lee MH, Amour A,Worley JR, Hutton M, et al. (2003). Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. Biochem Soc Symp 70:65-80.
98. Nair P, Gangadevi T, Jayaprakash P, Nair M, Nair M, Pillai M (1999). Increased angiogenesis in the uterine cervix associated with human papillomavirus infection. Pathol Res Pract 195:163-169.
99. Nakamura M, Bodily JM, Beglin M, Kyo S, Inoue M, Laimins LA (2009). Hypoxiaspecific stabilization of HIF-1alpha by human papillomaviruses. Virology 387:442-448.
100. Negri G, Romano F, Vittadello F, Kasal A, Mazzoleni G, Colombetti V, et al. (2006). Laminin-5 gamma2 chain immunohistochemistry facilitates the assessment of invasiveness and improves the diagnostic reproducibility of glandular lesions of the cervix uteri. Hum Pathol 37:704-710.
101. Nevin J, Laing D, Kaye P, McCulloch T, VArnard R, Silcocks P, et al. (1999). The significance of erb-b2 immunostaining in cervical cancer. Gynecol Oncol 73:254-258.
102. No JH, Jo H, Kim SH, Park IA, Kang D, Han SS, et al. (2009). Expression of vascular endothelial growth factor and hypoxia inducible factor-1alpha in cervical neoplasia. Ann N Y Acad Sci 1171:105-110.
103. Noel A, Maillard C, Rocks N, Jost M, Chabottaux V, Sounni NE, et al. (2004). Membrane associated proteases and their inhibitors in tumour angiogenesis. J Clin Pathol 57:577-584.
104. Noel JC, Fernandez-Aguilar S, Fayt I, Buxant F, Ansion MH, Simon P, et al. (2005). Laminin-5 gamma 2 chain expression in cervical intraepithelial neoplasia and invasive cervical carcinoma. Acta Obstet Gynecol Scand 84:1119-1123.
105. Obermair A,Wanner C, Bilgi S, Speiser P, Kaider A, Reinthaller A, et al. (1998). Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival. Am J Obstet Gynecol 178:314-319.
106. Overall CM, Kleifeld O (2006). Tumour microenvironment-opinion-validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6:227-239.
107. Overall CM, Lopez-Otin C (2002). Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:657-672.
108. Page-McCaw A, Ewald AJ, Werb Z (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8:221-233.
109. Pahler JC, Tazzyman S, Erez N, Chen YY, Murdoch C, Nozawa H, et al. (2008). Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. Neoplasia 10:329-340.
110. Pecorelli S, Zigliani L, Odicino F (2009). Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 105:107-108.
111. Petru E, Lück HJ, Stuart G, Gaffney D, Millan D, Vergote I, et al. (2009). Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. Eur J Obstet Gynecol Reprod Biol 143:69-74.
112. Phoophitphong T, Hanprasertpong J, Dechsukhum C, Geater A (2007). Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection. J Obstet Gynaecol Res 33:840-848.
113. Pilch H, Schlenger K, Steiner E, Brockerhoff P, Knapstein P, Vaupel P (2001). Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts. Int J Gynecol Cancer 11:137-142.
114. Pollard JW (2004). Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71-78.
115. Pyke C, Rømer J, Kallunki P, Lund LR, Ralfkiaer E, Danø K, et al. (1994). The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 145:782-791.
116. Quayle AJ, Anderson DJ (1994). Induction of mucosal immunity in the genital tract and prospects for oral vaccines. In: Talwar GP, Raghupathy R, editors. Birth control vaccines. USA: Landes Biosciences; pp. 149-165.
117. Raleigh JA, Calkins-Adams DP, Rinker LH, Ballenger C, Weissler M, Fowler WJ, et al. (1998). Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res 58:3765-3768.
118. Ramaswamy S, Ross KN, Lander ES, Golub TR (2003). A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49-54.
119. Randall LM, Monk B, Darcy KM, Tian C, Burger R, Liao S, et al. (2009). Markers of angiogenesis in high-risk, early-stage cervical cancer: a gynecologic oncology group study. Gynecol Oncol 112:583-589.
120. Ravazoula P, Zolota V, Hatjicondi O, Sakellaropoulos G, Kourounis G, Maragoudakis ME (1996). Assessment of angiogenesis in human cervical lesions. Anticancer Res 16:3861-3864.
121. Richart RM (1973). Cervical intraepithelial neoplasia. Pathol Annu 8:301-328.
122. Rio MC (2005). From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation. Biochimie 87:299-306.
123. Robertson SA, Ingman WV, O'Leary S, Sharkey DJ, Tremellen KP (2002). Transforming growth factor beta-a mediator of immune deviation in seminal plasma. J Reprod Immunol 57:109-128.
124. Roche WR (1986). The nature and significance of tumour-associated mast cells. J Pathol 148:175-182.
125. Rutgers J, Mattox T, Vargas M (1995). Angiogenesis in uterine cervical squamous cell carcinoma. Int J Gynecol Pathol 14:114-118.
126. Schoppmann S, Schindl M, Breiteneder-Geleff S, Soleima A, Breitenecker G, Karner B, et al. (2001). Inflammatory stromal reaction correlates with lymphatic microvessel density in early-stage cervival cancer. Anticancer Res 21:3419-3423.
127. Schoppmann S, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C (2002). Tumorassociated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161:947-956.
128. Scott KG (1963). The mast cell, its amines, and tumor growth in rodents and man. Ann NY Acad Sci 103:285-312.
129. Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM (2005). Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma. Cancer Res 65:2921-2929.
130. Skyldberg B, Salo S, Eriksson E, Aspenblad U, Moberger B, Tryggvason K, et al. (1999). Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 91:1882-1887.
131. Smith-Mccune KK,Weidner N (1994). Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 54:800-804.
132. Smith-Mccune K, Zhu Y, Hanahan D, Arbeit J (1997). Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res 57:1294-1300.
133. Smola-Hess S, Pahne J, Mauch C, Zigrino P, Smola H, Pfister HJ (2005). Expression of membrane type 1 matrix metalloproteinase in papillomaviruspositive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products. J Gen Virol 86:1291-1296.
134. Sotiropoulou M, Diakomanolis E, Elsheikh A, Loutradis D, Markaki S, Michalas S (2004). Angiogenic properties of carcinoma in situ and microinvasive carcinoma of the uterine cervix. Eur J Gynaecol Oncol 25:219-221.
135. Soufla G, Sifakis S, Baritaki S, Zafiropoulos A, Koumantakis E, Spandidos D (2005). VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix. Cancer Lett 221:105-118.
136. Sounni NE, Noel A (2005). Membrane type-matrix metalloproteinases and tumor progression. Biochimie 87:329-342.
137. Spelser P, Kirdelka F, Tempfer C, Ewards L, Leodolter S, Kainz C, et al. (1999). CD44v6 expression is an independent prognostic factor in node-negative FIGO stage IB cervical carcinoma. Int J Gynecol Cancer 9:160-165.
138. Sternlicht MD, Werb Z (2001). How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516.
139. Stoltzfus P, Salo S, Eriksson E, Aspenblad U, Tryggvason K, Auer G, et al. (2004). Laminin-5 gamma2 chain expression facilitates detection of invasive squamous cell carcinoma of the uterine cervix. Int J Gynecol Pathol 23:215-222.
140. Stöppler H, Malerczyk C, Block K, Aigner A, Czubayko F (2001). The human papillomavirus (HPV) 16 E6 oncoprotein leads to an increase in gene expression of the angiogenic switch molecule FGF-BP in non-immortalized human keratinocytes. Oncogene 20:7430-7436.
141. Tanaka H, Yasuda Y, Musha T, Ueda K, Nakamura Y (2005). Hypoxia correlates with angiogenesis in cervical cancers. Int J Clin Oncol 10:35-39.
142. Tang X, Zhang Q, Nishitani J, Brown J, Shi S, Le A (2007). Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. Clin Cancer Res 13:2568-2576.
143. Tirone NR, Peghini BC, Barcelos AC, Murta EF, Michelin MA (2009). Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia. Cancer Immunol Immunother 58:2003-2010.
144. Tjalma W, Van Marck E,Weyler J, Dirix L, Van Daele A, Goovaerts G, et al. (1998). Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. Br J Cancer 78:170-174.
145. TjalmaW, Sonnemans H,Weyler J, Van Marck E, Van Daele A, Van Dam P (1999). Angiogenesis in cervical intraepithelial neoplasia and the risk of recurrence. Am J Obstet Gynecol 181:554-559.
146. Tokumo K, Kodama J, Seki N, Nakanishi Y, Miyagi Y, Kamimura S, et al. (1998). Different angiogenic pathways in human cervical cancers. Gynecol Oncol 68:38-44.
147. Torisu H, Ono M, Kiryu H, Furue M, Ohmoto Y, Nakayama J, et al. (2000). Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNF alpha and IL-1 alpha. Int J Cancer 85:182-188.
148. Toussaint-Smith E, Donner DB, Roman A (2004). Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors. Oncogene 23:2988-2995.
149. Uthaisangsook S, Day NK, Bahna SL, Good RA, Haraguchi S (2002). Innate immunity and its role against infections. Ann Allergy Asthma Immunol 88:253-259.
150. Van Aarsen LA, Leone DR, Ho S, Dolinski BM, McCoon PE, LePage DJ, et al. (2008). Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. Cancer Res 68:561-570.
151. Van Lint P, Libert C (2006). Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev 17:217-223.
152. Van Trappen PO, Steele D, Lowe D, Baithun S, Beasley N, ThieleW, et al. (2003). Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol 201:544-554.
153. Van't Veer LJ, Dai HY, van de Vijver MJ, He YDD, Hart AAM, Mao M, et al. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536.
154. Vaupel P, Kelleher D, Hockel M (2001). Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 28:29-35.
155. Vazquez-Ortiz G, Pina-Sanchez P, Vazquez K, Duenas A, Taja L, Mendoza P, et al. (2005). Overexpression of cathepsin F, matrix metalloproteinases 11 and 12 in cervical cancer. BMC Cancer 5:68.
156. Venuti A, Salani D, Cirilli A, Simeone P, Muller A, Flamini S, et al. (2002). Endothelin receptor blockade inhibits the growth of human papillomavirusassociated cervical carcinoma. Clin Sci (Lond) 103 (Suppl 48):310S-313S.
157. Visse R, Nagase H (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827-839.
158. Vogelstein B, Kinzler KW (2004). Cancer genes and the pathways they control. Nat Med 10:789-799.
159. Wadler S, Burk RD, Neuberg D, Rameau R, Runowicz CD, Goldberg G, et al. (1995). Lack of efficacy of interferon-therapy in recurrent, advanced cervical cancer. J Interferon Cytokine Res 15:1011-1016.
160. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer
161. Wiggins DL, Granai C, Steinhoff M, Calabresi P (1995). Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol 56:353-356.
162. Yamashita H, Murakami N, Asari T, Okuma K, Ohtomo K, Nakagawa K (2009). Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer. Int J Radiat Oncol Biol Phys 74:1165-1172.
163. Zaghloul M, El Naggar M, El Deeb A, Khaled H, Mokhtar N (2000). Prognostic implication of apoptosis and angiogenesis in cervical uteri cancer. Int J Radiat Oncol Biol Phys 48:1409-1415.
164. Zijlmans HJMAA, Fleuren GJ, Baelde HJ, Eilers PHC, Kenter GG, Gorter A (2007). Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma. Cancer 109:556-565.